לפונקס 100 מג טבליות
devries & co. ltd - clozapine - טבליה - clozapine 100 mg
עזרקאין ג'ל
rafa laboratories ltd - lidocaine hydrochloride - ג'ל - lidocaine hydrochloride 2 % - local anesthetic, not to be used for procedures requiring sterile products
קלגרון תפוז
rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - לכסניה - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine
קלגרון מנטה
rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - לכסניה - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine
קלגרון תות
rafa laboratories ltd - cetylpyridinium chloride; lidocaine hydrochloride ( as monohydrate) - לכסניה - cetylpyridinium chloride 1.25 mg; lidocaine hydrochloride ( as monohydrate) 1 mg - lidocaine
אורוקורט e
taro pharmaceutical industries ltd - lidocaine hydrochloride monohydrate; triamcinolone acetonide - פסטה - lidocaine hydrochloride monohydrate 3 g / 100 g; triamcinolone acetonide 0.1 g / 100 g - triamcinolone - triamcinolone - adjunctive treatment and temporary relief of symptoms associated with inflammatory lesions in the oral cavity.
פרוקטו-גליבנול קרם
gsk consumer healthcare, israel ltd - lidocaine hydrochloride; tribenoside - קרם - tribenoside 5 %; lidocaine hydrochloride 2.12 % - tribenoside - tribenoside - external & internal haemorrhoids
פרוקטו-גליבנול פתילות
gsk consumer healthcare, israel ltd - lidocaine; tribenoside - פתילות - tribenoside 400 mg; lidocaine 40 mg - tribenoside - tribenoside - local relief of haemorrhoids.
לידוקדרן טבע
abic marketing ltd, israel - epinephrine as bitartrate; lidocaine hydrochloride - תמיסה להזרקה - lidocaine hydrochloride 36 mg / 1.8 ml; epinephrine as bitartrate 22.5 mcg / 1.8 ml - lidocaine, combinations - anesthetics, local - production of local anasthesia by nerve-block infiltration technique.
לפונקס 25 מ"ג טבליות
novartis pharma services ag - clozapine 25 mg - tablets - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death.